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The calf vaccinating table
Samson SY Wong, FRCPath, FHKCPath
Member, Education and Research Committee, Hong Kong Museum of Medical Sciences Society
This has to be the highlight of any visit to the Hong 
Kong Museum of Medical Sciences—mannequins 
of two men and a buffalo calf on a table, the calf 
vaccinating table (Figs 1 and 2c). The existing calf 
table was transferred to the Hong Kong Museum of 
Medical Sciences by the Department of Health in 
1996. The table was manufactured locally and was in 
use from the mid-1940s to the 1970s. A description 
on the equipment that accompanied the transfer is 
as follows1 (Fig 2a):
In the process of smallpox vaccine production, 
a buffalo calf was led to stand alongside the 
teak table top which has been hinged vertically. 
The calf was fastened manually on the table. 
The holes and grooves on the table top were 
devices to drain off the cleansing water. Once 
the animal was immobile [sic], the table top 
was hinged upwards with the calf lying on 
it horizontally. The calf ’s right leg was then 
fastened to the curved, iron retort stand so that 
its belly was completely exposed and ready for 
shaving, cleansing, disinfecting and eventually 
vaccinating by scarification. 
 The table is the most recognisable relic of a 
unique function of the old Bacteriological Institute, 
viz vaccine production. The Bacteriological Institute 
produced smallpox vaccine from the early 1900s until 
1973.2 Records indicate that when the Government 
Bacteriologist took over the role of Director of the 
Government Vaccine Institute in October 1902, 
4616 tubes of smallpox vaccine had been produced 
from 23 calves in that year.3 The vaccines produced 
were not only used locally (hospitals and private 
doctors), but also delivered to the naval and military 
authorities, as well as Canton and other neighbouring 
ports.3 The annual quantity of vaccines produced 
varied. For example, following a local epidemic of 
smallpox, 137 646 tubes of vaccine were issued in 
1923.4 It is interesting to note that the initial uptake 
of smallpox vaccination in the local population was 
rather lukewarm, but it increased after 1928 as a 
result of greater community engagement by various 
non-governmental organisations.5
 Smallpox was one of the deadliest infectious 
diseases of mankind until 1977. Hong Kong was free 
from the disease for 2 years before being declared 
smallpox-free in July 1979.6 Vaccination played a 
crucial role in global eradication of the disease. 
The story of cowpox vaccination by Edward Jenner 
in 1796 marked the earliest systematic use of 
human vaccination for the prevention of infectious 
diseases. The first-generation smallpox vaccines 
were originally produced by inoculating animals 
with infectious materials by scarification, followed 
by harvesting of the vesicle fluid (the so-called 
‘lymph’) from the animals and subsequent storage 
of the vaccine as a freeze-dried product (Fig 2b). 
Calves were most commonly used for this purpose, 
although donkeys and horses could also be used.7 
Buffalo calves were kept in the animal house of the 
Bacteriological Institute for this purpose. Similar 
tables were used in other countries in the past for 
vaccinating calves and harvesting of lymph.8
 The form of smallpox encountered in Hong 
Kong was mostly variola major, the more severe 
form of the disease with an overall case-fatality ratio 
of around 30%.9 Although smallpox was a statutory 
notifiable disease even in the early days of colonial 
Hong Kong, it was estimated that as many as two 
thirds of cases were not notified because many local 
Chinese considered it a relatively minor condition 
that was managed by herbalists.5 Dr Uttley, a local 
medical officer, reported a crude death rate from 
smallpox of 0.46 per 1000 population (range, 0.01-
2.27 per 1000) for the years 1897 to 1936.5 Mortality 
of smallpox among the local Chinese was highest 
among children, with 53% of fatal cases occurring 
in children under 3 years of age, and 72% occurring 
in children under 5. In contrast, in contemporary 
England and Wales, smallpox mortality was highest 
among adults aged 25 to 45 years. The discrepancy 
was believed to be due to better childhood smallpox 
FIG 1.  The calf vaccinating table in the Hong Kong Museum of 
Medical Sciences
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FIG 3.  Local relics of the history of 
smallpox in Hong Kong
(a) Grave of a local smallpox victim in the 
19th century located in the Hong Kong 
Cemetery. Inscriptions on the headstone 
of the grave read, “In memory of the 
late John L. Langan, torpedo instructor of 
HMS Undaunted, who died of smallpox at 
Hong Kong on 15th February 1899, aged 
31 years.” (b) Remains of the Tung Wah 
Smallpox Hospital, A.D. 1910, currently 
located in Sai Ning Street, Kennedy Town. 
Foundation stone laid by Sir Henry Arthur 
Blake, G.C.M.G., Governor of the Colony 
of Hong Kong, on 18 November 1901. 
Inscription on the top of the foundation 
stone reads, “The arch and the foundation 
stone were once part of the Tung Wah 
Smallpox Hospital, completed in 1910, 
not far from this spot. In 1938, the building 
became the Government Infectious 
Disease Hospital, and was demolished after 
the Second World War.”
FIG 2.  (a) Staff of the old Pathological Institute vaccinating a buffalo calf. From Hong Kong Museum of Medical Sciences Archives, 
donated to the Hong Kong Museum of Medical Sciences Society by staff of the former Pathological Institute. (b) Finished product of 
the smallpox vaccine manufactured by the Bacteriological Institute. (c) Present-day demonstration of smallpox vaccine production 
on the calf vaccinating table
(a) (c)
(b)
(a) (b)
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immunisation coverage in England and Wales with 
subsequent waning of immunity during adulthood.5 
Although smallpox had been a scourge of mankind 
for centuries, few relics of the history of smallpox 
remain in Hong Kong. Today, a tomb of a young 
naval officer who died from smallpox in the late 
19th century in Hong Kong can still be found 
(Fig 3a). Another indication of the public health 
significance of the disease in Hong Kong was the 
Tung Wah Smallpox Hospital, of which only the 
arch and foundation stone remain (Fig 3b). It was 
built originally to house plague patients in 1902 and 
converted to become one of the several early health 
care facilities dedicated to the care of smallpox 
patients. It was later changed to an infectious disease 
hospital prior to its demolition.6
 Although smallpox has been eradicated for 40 
years, lessons from the virus and the disease remain 
relevant to us today. Routine vaccination against 
smallpox is no longer necessary but vaccination is 
still implemented in certain special populations, such 
as military personnel in some countries or laboratory 
workers who handle poxviruses.10-13 Research on 
smallpox and related vaccines remains active in the 
ever-present threat of bioterrorism and the need 
for protection against other poxvirus infections of 
humans, such as monkeypox. Newer second-, third-, 
and fourth-generation smallpox vaccines have been 
developed using cell cultures of live-attenuated viruses 
or recombinant subunits, although only very few 
of these newer-generation vaccines (eg ACAM200, 
Sanofi Pasteur) have been licensed for human use.14,15 
The vaccinia virus and its derivatives, as well as other 
poxviruses, have also found new life in medicine as 
they may serve as vaccine vectors against a number 
of infectious diseases and even for treatment of 
cancers because of their oncolytic properties.14,16 
Last but not the least, as the only human infectious 
disease that has ever been eradicated through human 
interventions, the story of smallpox remains an 
invaluable legacy in public health and other disease 
eradication programmes.17
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